on BASTIDE (EPA:BLC)
Sale of subsidiaries Cicadum and Medsoft by the Bastide Group
The Bastide Group, a home healthcare specialist, has announced the sale of its subsidiaries Cicadum and Medsoft. Cicadum, 51% owned, and Medsoft, wholly owned, focus on stoma therapy. Both companies were sold to their founders after generating a combined revenue of €11 million for the 2023-2024 fiscal year.
This transaction, carried out in cash, is intended to improve the group's margin and reduce its net financial debt. The Bastide Group is also continuing to explore the sale of other assets that no longer align with its overall strategy.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all BASTIDE news